QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
(Address of principal executive offices) |
(Zip Code) | |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-fifth of one redeemable warrant |
||||
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
| Emerging growth company | ||||||
Page |
||||
Part I. Financial Information |
||||
Item 1. Financial Statements |
||||
1 |
||||
2 |
||||
3 |
||||
4 |
||||
5 |
||||
21 |
||||
24 |
||||
24 |
||||
25 |
||||
25 |
||||
25 |
||||
26 |
||||
27 |
||||
27 |
||||
27 |
||||
28 |
||||
29 |
||||
| ASSETS |
||||
| Current assets |
||||
| Cash |
$ | |||
| Prepaid expenses |
||||
| |
|
|||
| Total current assets |
||||
| Investments held in Trust Account |
||||
| |
|
|||
| TOTAL ASSETS |
$ |
|||
| |
|
|||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT |
||||
| Current liabilities |
||||
| Accrued expenses |
$ | |||
| |
|
|||
| Total current liabilities |
||||
| Warrant liabilities |
||||
| Deferred underwriting fee payable |
||||
| |
|
|||
| Total Liabilities |
||||
| Commitments |
||||
| Class A ordinary shares subject to possible redemption |
||||
| Shareholders’ Deficit |
||||
| Preference shares, $ |
||||
| Class A ordinary shares, $ |
||||
| Class B ordinary shares, $ |
||||
| Additional paid-in capital |
||||
| Accumulated Deficit |
( |
) | ||
| |
|
|||
| Total Shareholders’ Deficit |
( |
) | ||
| |
|
|||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT |
$ |
|||
| |
|
Three Months Ended September 30, |
For The Period from January 8, 2021 (Inception) Through September 30, |
|||||||
2021 |
2021 |
|||||||
| General and administrative expenses |
$ | $ | ||||||
| |
|
|
|
|||||
| Loss from operations |
( |
) |
( |
) | ||||
| Other income: |
||||||||
| Change in fair value of warrant liabilities |
||||||||
| Transaction costs allocated to warrant liabilities |
— | ( |
) | |||||
| Interest income – bank |
||||||||
| Interest earned on investments held in Trust Account |
||||||||
| |
|
|
|
|||||
| Total other income, net |
||||||||
| |
|
|
|
|||||
| Net income |
$ |
$ |
||||||
| |
|
|
|
|||||
| Weighted average shares outstanding of Class A ordinary shares |
||||||||
| |
|
|
|
|||||
| Basic and diluted net income per share, Class A ordinary shares |
$ |
$ |
||||||
| |
|
|
|
|||||
| Weighted average shares outstanding of Class B ordinary shares |
||||||||
| |
|
|
|
|||||
| Basic and diluted net income per share, Class B ordinary shares |
$ |
$ |
||||||
| |
|
|
|
|||||
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in |
Accumulated |
Total Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
| Balance — January 8, 2021 (inception) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
| Issuance of Class B ordinary shares to Sponsor |
||||||||||||||||||||||||||||
| Cash paid in excess of fair value of P rivate P lacementW arrants |
— |
— |
||||||||||||||||||||||||||
| Accretion for Class A ordinary shares to redemption amount |
— | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
| Forfeiture of Founder Share s |
( |
) | ( |
) | ||||||||||||||||||||||||
| Net income |
— |
— |
||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – March 31, 2021, as restated – see Note 2 (unaudited) |
( |
) |
( |
) | ||||||||||||||||||||||||
| Net loss |
— |
— |
( |
) | ( |
) | ||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – June 30, 2021, as restated – see Note 2 (unaudited) |
( |
) |
( |
) | ||||||||||||||||||||||||
| Net income |
— | — | ||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – September 30, 2021 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Cash Flows from Operating Activities: |
||||
| Net income |
$ | |||
| Adjustments to reconcile net income to net cash used in operating activities: |
||||
| Formation costs paid by S ponsor |
||||
| Interest earned on investments held in Trust Account |
( |
) | ||
| Change in fair value of warrant liabilities |
( |
) | ||
| Transaction costs allocated to warrant liabilities |
||||
| Changes in operating assets and liabilities: |
||||
| Prepaid expenses |
( |
) | ||
| Accrued expenses |
||||
| |
|
|||
| Net cash used in operating activities |
( |
) | ||
| |
|
|||
| Cash Flows from Investing Activities: |
||||
| Investment of cash in Trust Account |
( |
) | ||
| |
|
|||
| Net cash used in investing activities |
( |
) | ||
| |
|
|||
| Cash Flows from Financing Activities: |
||||
| Proceeds from sale of Units, net of underwriting discounts paid |
||||
| Proceeds from sale of Private Placement Warrants |
||||
| Proceeds from P romissory N ote – related party |
||||
| Repayment of P romissory N ote – related party |
( |
) | ||
| Payment of offering costs |
( |
) | ||
| |
|
|||
| Net cash provided by financing activities |
||||
| |
|
|||
| Net Change in Cash |
||||
| Cash – Beginning of period |
||||
| |
|
|||
| Cash – End of period |
$ |
|||
| |
|
|||
| Non-Cash investing and financing activities: |
||||
| Offering costs paid by Sponsor in exchange for the issuance of F ounder S hares |
$ | |||
| |
|
|||
| Offering costs paid through P romissory N ote |
$ | |||
| |
|
|||
| Deferred underwriting fee payable |
$ | |||
| |
|
|
|
|
| Forfeiture of F ounder S hares |
$ | ( |
) | |
| |
|
As Previously Reported |
Adjustment |
As Restated |
||||||||||
| Condensed Balance Sheet as of March 31, 2021 (unaudited) |
||||||||||||
| Class A ordinary shares subject to possible redemption |
$ | $ | $ | |||||||||
| Class A ordinary shares |
$ | $ | ( |
) | $ | |||||||
| Additional paid-in capital |
$ | $ | ( |
) | $ | |||||||
| Retained earnings (accumulated deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
| Total Shareholders’ Equity (Deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
| Condensed Balance Sheet as of June 30, 2021 (unaudited) |
||||||||||||
| Class A ordinary shares subject to possible redemption |
$ |
$ |
$ |
|||||||||
| Class A ordinary shares |
$ |
$ |
( |
) |
$ |
|||||||
| Additional paid-in capital |
$ |
$ |
( |
) |
$ |
|||||||
| Accumulated deficit |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| Total Shareholders’ Equity (Deficit) |
$ |
$ |
( |
) |
$ |
( |
) | |||||
| Condensed Statement of Changes in Shareholder’s Equity (Deficit) for the Period from January 8, 2021 (Inception) Through March 31, 2021 ( una udited) |
||||||||||||
| Sale of 40,845,476 Units, net of underwriting discounts, offering costs, and initial fair value of Public Warrants |
$ |
$ |
( |
) |
$ |
|||||||
| Class A ordinary shares subject to redemption |
$ |
( |
) |
$ |
$ |
|||||||
| Accretion for Class A ordinary shares to redemption amount |
$ |
$ |
( |
) |
$ |
( |
) | |||||
| Condensed Statement of Changes in Shareholders’ Equity (Deficit) for the Three Months Ended June 30, 2021 (Unaudited) |
||||||||||||
| Change in Class A ordinary shares to redemption amount |
$ |
$ |
( |
) |
$ |
|||||||
| Condensed Statement of Operations for the Period from January 8, 2021 (Inception) Through March 31, 2021 (Unaudited) |
||||||||||||
| Weighted average shares outstanding, Class A ordinary shares |
( |
) |
||||||||||
| Basic and diluted net income per share Class A ordinary shares |
$ |
|||||||||||
| Weighted average shares outstanding, Class B ordinary shares |
( |
) |
||||||||||
| Basic and diluted net income per share Class B ordinary shares |
$ |
( |
) |
|||||||||
| Condensed Statement of Operations for the Three Months Ended June 30, 2021 (Unaudited) |
||||||||||||
| Weighted average shares outstanding, Class A ordinary shares |
||||||||||||
| Basic and diluted net loss per share Class A ordinary shares |
$ |
( |
) |
( |
) | |||||||
| Weighted average shares outstanding, Class B ordinary shares |
||||||||||||
| Basic and diluted net loss per share Class B ordinary shares |
$ |
( |
) |
( |
) | |||||||
| Condensed Statement of Operations for the Period from January 8, 2021 (Inception) through June 30, 2021 (Unaudited) |
||||||||||||
| Weighted average shares outstanding, Class A ordinary shares |
( |
) |
||||||||||
| Basic and diluted net loss per share Class A ordinary shares |
$ |
( |
) |
( |
) | |||||||
| Weighted average shares outstanding, Class B ordinary shares |
( |
) |
||||||||||
| Basic and diluted net loss per share Class B ordinary shares |
$ |
( |
) |
( |
) | |||||||
| Condensed Statement of Cash Flows for the Period from January 8, 2021 (Inception) through March 31, 2021 (Unaudited) |
||||||||||||
| Non-cash investing and financing activities: |
||||||||||||
| Initial classification of ordinary shares subject to possible redemption |
$ |
$ |
( |
) | $ |
|||||||
| Change in value of ordinary shares subject to possible redemption |
$ |
$ |
( |
) |
$ |
|||||||
| Condensed Statement of Cash Flows for the Period from January 8, 2021 (Inception) through June 30, 2021 (Unaudited) |
||||||||||||
| Non-cash investing and financing activities: |
||||||||||||
| Initial classification of ordinary shares subject to possible redemption |
$ |
$ |
( |
) |
$ |
|||||||
| Change in value of ordinary shares subject to possible redemption |
$ |
$ |
( |
) |
$ |
|||||||
Gross proceeds |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
$ | ( |
) | |
Class A ordinary shares issuance costs |
$ | ( |
) | |
Plus: |
||||
Accretion of carrying value to redemption value |
$ | |||
Class A ordinary shares subject to possible redemption |
$ | |||
Three Months Ended September 30, 2021 |
For the Period from January 15, 2021 (inception) through September 30, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income per ordinary share |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income, as adjusted |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average shares outstanding |
||||||||||||||||
Basic and diluted net income per ordinary share |
$ | $ | $ | $ | ||||||||||||
| • | in whole and not in part; |
| • | at a price of $ |
| • | upon a minimum of |
| • | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $ sub-divisions, share dividends, reorganizations, recapitalizations and the like) for any |
| • | in whole and not in part; |
| • | at $ |
| • | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $ sub-divisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
| • | if the closing price of the Class A ordinary shares for any sub-divisions, share dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Description |
Level |
September 30, 2021 |
||||||
Assets: |
||||||||
Investments held in Trust Account – U.S. Treasury Securities Money Market Fund |
1 | $ | ||||||
Liabilities: |
||||||||
September 30, 2021 – Public Warrants |
1 | |||||||
September 30, 2021 – Private Placement Warrants |
2 | |||||||
Public |
Private Placement |
Warrant Liabilities |
||||||||||
Fair value as of Inception |
$ | $ | $ | |||||||||
Initial measurement on March 11, 2021 |
||||||||||||
Change in valuation inputs or other assumptions |
( |
) | ( |
) | ( |
) | ||||||
Fair value as of March 31, 2021 |
$ | $ | $ | |||||||||
Change in valuation inputs or other assumptions |
||||||||||||
Transfer to Level 1 |
( |
) | ( |
) | ||||||||
Transfer to Level 2 |
( |
) | ( |
) | ||||||||
Fair value as of June 30, 2021 |
||||||||||||
Fair value as of September 30, 2021 |
||||||||||||
No. |
Description of Exhibit | |
| 31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 31.2* | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32.1** | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 32.2** | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 101.INS* | Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document | |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104 | The cover page for the Company’s Quarterly Report has been formatted in Inline XBRL and contained in Exhibit 101 | |
| * | Filed herewith. | |
| ** | Furnished. | |
PERIDOT ACQUISITION CORP. II | ||||||
| Date: February 15, 202 2 |
/s/ Preston Powell | |||||
| Name: | Preston Powell | |||||
| Title: | Chief Executive Officer (Principal Executive Officer) | |||||
| Date: February 15, 20 22 |
/s/ Stephen Wedemeyer | |||||
| Name: | Stephen Wedemeyer | |||||
| Title: | Chief Financial Officer (Principal Financial Officer and Accounting Officer) | |||||